wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50116255-0C52E08B-A49F-49B9-BDFF-62C4EC37AD17
Q50116255-0C52E08B-A49F-49B9-BDFF-62C4EC37AD17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-0C52E08B-A49F-49B9-BDFF-62C4EC37AD17
Talimogene Laherparepvec: First in Class Oncolytic Virotherapy.
P2860
Q50116255-0C52E08B-A49F-49B9-BDFF-62C4EC37AD17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-0C52E08B-A49F-49B9-BDFF-62C4EC37AD17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b04ba680bd1fa30c74982cddf16478f7a578bdbd
P2860
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial